Abstract
Endothelial nitric oxide (NO) plays important roles in the vascular system. Animal models that show vascular dysfunction demonstrate the protective role of endothelial NO dependent pathways. This review focuses on the role of endothelial NO in the regulation of cerebral blood flow and vascular tone. We will discuss the importance of NO in cerebrovascular function using animal models with altered endothelial NO production under normal, ischemic and reperfusion conditions, as well as in hyperoxia. Pharmacological and genetic manipulations of the endothelial NO system demonstrate the essential roles of endothelial NO synthase in maintenance of vascular tone and cerebral perfusion under normal and pathological conditions.
Keywords: Cerebrovascular regulation, endothelial nitric oxide synthase, mutant mice, Cerebral blood flow (CBF), neurogenic stimulation, nitrergic perivascular nerves, inflammatory conditions, vascular reactivity, tethrahydrobiopterin, soluble guanylyl cyclase, potassium channels, cerebral artery, cerebrovascular reactivity, downstream guanylate cyclase, brain vasculature
Current Pharmaceutical Biotechnology
Title: Role of Endothelial Nitric Oxide in Cerebrovascular Regulation
Volume: 12 Issue: 9
Author(s): Dmitriy N. Atochin and Paul L. Huang
Affiliation:
Keywords: Cerebrovascular regulation, endothelial nitric oxide synthase, mutant mice, Cerebral blood flow (CBF), neurogenic stimulation, nitrergic perivascular nerves, inflammatory conditions, vascular reactivity, tethrahydrobiopterin, soluble guanylyl cyclase, potassium channels, cerebral artery, cerebrovascular reactivity, downstream guanylate cyclase, brain vasculature
Abstract: Endothelial nitric oxide (NO) plays important roles in the vascular system. Animal models that show vascular dysfunction demonstrate the protective role of endothelial NO dependent pathways. This review focuses on the role of endothelial NO in the regulation of cerebral blood flow and vascular tone. We will discuss the importance of NO in cerebrovascular function using animal models with altered endothelial NO production under normal, ischemic and reperfusion conditions, as well as in hyperoxia. Pharmacological and genetic manipulations of the endothelial NO system demonstrate the essential roles of endothelial NO synthase in maintenance of vascular tone and cerebral perfusion under normal and pathological conditions.
Export Options
About this article
Cite this article as:
N. Atochin Dmitriy and L. Huang Paul, Role of Endothelial Nitric Oxide in Cerebrovascular Regulation, Current Pharmaceutical Biotechnology 2011; 12 (9) . https://dx.doi.org/10.2174/138920111798280974
DOI https://dx.doi.org/10.2174/138920111798280974 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamins in Heart Failure: Friend or Enemy?
Current Pharmaceutical Design Buccoadhesive Dosage Form Containing Antifungal Agent for Treating Oropharyngeal Candidiasis: A Review
Current Drug Therapy State of the Heart: CMR in Coronary Artery Disease
Current Medical Imaging Neuroinflammation and Immunity: A New Pharmacological Target in Depression
CNS & Neurological Disorders - Drug Targets Development and Characterization Pulsatile Microspheres of Nifedipine for Hypertension
Recent Patents on Drug Delivery & Formulation Mediterranean Diet Rich in Olive Oil and Obesity, Metabolic Syndrome and Diabetes Mellitus
Current Pharmaceutical Design Preparation and Evaluation of Chitosan Submicroparticles Containing Pilocarpine for Glaucoma Therapy
Current Drug Delivery Recent Advances in Pathophysiology of Traumatic Brain Injury
Current Neuropharmacology Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis
Current Drug Targets Mitochondria-Targeted Drugs
Current Molecular Pharmacology Development of Nanocomponent Ointment Composition for the Treatment of Various Etiologies Wounds
Current Nanomedicine Improving the Efficiency and Safety of Aspirin by Complexation with the Natural Polysaccharide Arabinogalactan
Current Drug Delivery Microcirculation in Hypertension: An Update on Clinical Significance and Therapy
Current Vascular Pharmacology Recent Developments on Coronary Microvasculopathy after Heart Transplantation:A New Target in the Therapy of Cardiac Allograft Vasculopathy
Current Vascular Pharmacology Biologically Responsive Nanosystems Targeting Cardiovascular Diseases
Current Drug Delivery Abnormal Insulin Signaling: Early Detection of Silent Coronary Artery Disease-Erectile Dysfunction?
Current Pharmaceutical Design Involvement of Orexigenic Peptides in the Mechanism of Gastric Mucosal Integrity and Healing of Chronic Gastric Ulcers
Current Pharmaceutical Design Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery Functional and Structural Alterations of Large Arteries: Methodological Issues
Current Pharmaceutical Design The Role of Coronary Physiology in Contemporary Percutaneous Coronary Interventions
Current Cardiology Reviews